A detailed history of Hall Capital Management CO Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Hall Capital Management CO Inc holds 17,800 shares of ABBV stock, worth $2.98 Million. This represents 1.6% of its overall portfolio holdings.

Number of Shares
17,800
Previous 17,785 0.08%
Holding current value
$2.98 Million
Previous $2.76 Million 17.6%
% of portfolio
1.6%
Previous 1.62%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $2,397 - $2,731
15 Added 0.08%
17,800 $3.24 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $249,331 - $280,805
-1,812 Reduced 9.25%
17,785 $2.76 Million
Q3 2023

Oct 10, 2023

SELL
$133.59 - $154.65 $2.27 Million - $2.62 Million
-16,969 Reduced 46.41%
19,597 $2.92 Million
Q2 2023

Aug 07, 2023

BUY
$132.51 - $164.9 $18,551 - $23,086
140 Added 0.38%
36,566 $4.93 Million
Q1 2023

Apr 17, 2023

SELL
$144.61 - $166.54 $124,219 - $143,057
-859 Reduced 2.3%
36,426 $5.81 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $24,480 - $29,358
177 Added 0.48%
37,285 $6.03 Million
Q3 2022

Oct 18, 2022

BUY
$134.21 - $153.93 $104,415 - $119,757
778 Added 2.14%
37,108 $4.98 Million
Q2 2022

Jul 19, 2022

SELL
$137.62 - $174.96 $90,141 - $114,598
-655 Reduced 1.77%
36,330 $5.56 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $5,279 - $6,550
40 Added 0.11%
36,985 $6 Million
Q4 2021

May 04, 2022

BUY
$107.43 - $135.93 $116,561 - $147,484
1,085 Added 3.03%
36,945 $5 Million
Q3 2021

Oct 08, 2021

BUY
$106.4 - $120.78 $41,283 - $46,862
388 Added 1.09%
35,860 $3.87 Million
Q2 2021

Jul 14, 2021

SELL
$105.21 - $117.21 $270,600 - $301,464
-2,572 Reduced 6.76%
35,472 $4 Million
Q4 2020

Mar 02, 2021

BUY
$80.49 - $108.67 $149,308 - $201,582
1,855 Added 5.13%
38,044 $4.08 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $81,786 - $95,990
952 Added 2.7%
36,189 $3.17 Million
Q2 2020

Nov 16, 2020

BUY
$73.37 - $98.18 $101,177 - $135,390
1,379 Added 4.07%
35,237 $3.46 Million
Q1 2020

Apr 29, 2020

BUY
$64.5 - $97.79 $121,905 - $184,823
1,890 Added 5.91%
33,858 $2.58 Million
Q4 2019

Feb 04, 2020

BUY
$72.13 - $90.25 $2,019 - $2,527
28 Added 0.09%
31,968 $2.83 Million
Q3 2019

Oct 15, 2019

SELL
$62.98 - $75.72 $18,894 - $22,716
-300 Reduced 0.93%
31,940 $2.42 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $1,314 - $1,679
20 Added 0.06%
32,240 $2.34 Million
Q1 2019

May 06, 2019

SELL
$77.14 - $90.79 $53,612 - $63,099
-695 Reduced 2.11%
32,220 $2.6 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $70,843 - $87,369
-910 Reduced 2.69%
32,915 $3.03 Million
Q3 2018

Nov 05, 2018

BUY
$88.91 - $98.84 $13,336 - $14,826
150 Added 0.45%
33,825 $3.2 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $8,708 - $10,304
-97 Reduced 0.29%
33,675 $3.12 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $285,691 - $382,567
-3,105 Reduced 8.42%
33,772 $3.2 Million
Q4 2017

Feb 02, 2018

SELL
$89.56 - $98.21 $113,741 - $124,726
-1,270 Reduced 3.33%
36,877 $3.57 Million
Q3 2017

Oct 19, 2017

SELL
$69.85 - $89.22 $6,356 - $8,119
-91 Reduced 0.24%
38,147 $3.39 Million
Q2 2017

Aug 14, 2017

BUY
N/A
38,238
38,238 $2.77 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hall Capital Management CO Inc Portfolio

Follow Hall Capital Management CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hall Capital Management CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hall Capital Management CO Inc with notifications on news.